Clinical Trials Logo

BRAF-mutated Metastatic Melanoma clinical trials

View clinical trials related to BRAF-mutated Metastatic Melanoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT01876641 Terminated - Melanoma Clinical Trials

Treatment of a Resistant Disease Using Decitabine Combined With Vemurafenib Plus Cobimetinib

ML28604
Start date: October 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is to see if the combination of Vemurafenib with Decitabine plus Cobimetinib improves the low therapy response rate in subjects with malignant melanoma.